On Demand Webinar

Continuous Kidney Replacement Therapy (CKRT) Basics

Are you new to Continuous Kidney Replacement Therapy (CKRT) or just want to increase your knowledge?  Do you want to ensure that you’re providing your patients with individualized CKRT care while in the ICU?  Watch CKRT Basics to receive an overview of:

• CKRT modalities
• Patient selection
• Dosing
• Anticoagulation and medication dosing
• Potential complications
• Introduction to hybrid therapy (PIKRT, AVVH, etc.)



Casey Gashti, MD
Associate Professor of Nephrology and Medical Director for Inpatient Plasmapheresis
Rush University Medical Center
Chicago, IL

Dr. Casey Gashti* is board certified in Nephrology and Internal Medicine and is affiliated with Rush University Medical Center, Chicago, Illinois. He completed his residency in Internal Medicine and his Fellowship in Nephrology at Rush University Medical Center, where he is currently Associate Professor of Nephrology and the Medical Director for Inpatient Plasmapheresis. Dr. Gashti is a member of the American College of Physicians (ACP), American Society for Apheresis (AFSA) and the American Society of Nephrology (ASN).

*Paid speaker for NxStage Medical, Inc.



Watch Webinar now

Complete this form to register for the webcast.



Renal replacement therapy, as with any medical therapy, is not without risks. The decision of which therapy to use should be made by the physician, based on previous experience and on the individual facts and circumstances of the patient. There is no literature demonstrating one therapy is clinically better than another.1

1. D. M. Nash, S. Przech, R. Wald, and D. O’Reilly, “Systematic review and meta-analysis of renal replacement therapy modalities for acute kidney injury in the intensive care unit,” Journal of Critical Care, vol. 41, pp. 138–144, 2017.

CAUTION: Federal law restricts this device to sale by or on the order of a physician. 

© 2021 Fresenius Medical Care. All Rights Reserved. Fresenius Medical Care, the triangle logo, and NxStage are trademarks of Fresenius Medical Care Holdings, Inc. or its affiliated companies. All other trademarks are the property of their respective owners. P/N 104737-01 REV B 10/2021 / APM4252 REV B